Pulmonology
Pirfenidone PSK
Registration certificate:
INN:
pirfenidone
Release form:
Film-coated tablets
Therapeutic Area:
Pulmonology
Pharmacotherapeutic Group:
An immunosuppressive agent
Packaging:

Indications: Pirfenidone PSK is indicated for use in adults aged 18 years and older for the treatment of idiopathic pulmonary fibrosis (IPF).

This product is included in the Essential Drug List (EDL).

Prescription Status: Rx only.

THERE ARE CONTRAINDICATIONS. PLEASE CONSULT A HEALTHCARE PROFESSIONAL BEFORE USE.

For the full medical use instructions of Pirfenidone PSK (INN: pirfenidone), film-coated tablets, please visit the official website: https://grls.rosminzdrav.ru/Default.aspx.

Quality control
at all stages of production